脚伤 我在处二是搞到了脚,痛的一星期走不了路
发布网友
发布时间:2022-04-27 05:20
我来回答
共2个回答
热心网友
时间:2022-06-26 20:45
FDA News2007-07-14 10:53The Food and Drug Administration (FDA) today confirmed that a strain of Salmonella Wandsworth bacteria found in Veggie Booty snack food is responsible for the disease outbreak that occurred between March and June 2007.
Epidemiological testing concted by the Minnesota Agricultural Lab previously implicated Veggie Booty snack food as the source of the outbreak. The results of FDA’s own testing added confirmation.
Veggie Booty is marketed by Robert’s American Gourmet, of Sea Cliff, N.Y.
FDA continues to advise consumers not to eat any Veggie Booty and to throw away proct they have. FDA also advises consumers not to eat Super Veggie Tings Crunchy Corn Sticks, and to throw out any supplies they have, because this proct also may be contaminated.
No illnesses have been associated with any other Robert's American Gourmet procts.
Salmonella typically causes diarrhea (may be bloody), often accompanied by abdominal cramps and fever. Symptoms typically begin within one to four days after exposure to the bacteria. In infants and persons with poor underlying health and those with weakened immune systems, Salmonella can invade the bloodstream and cause life-threatening infections.
Indivials who have recently eaten Veggie Booty or Super Veggie Tings Crunchy Corn Sticks and who have experienced any of the symptoms described below should contact a doctor or other health care provider immediately. Both procts may appeal to children, so parents should be especially vigilant and seek medical care if they observe signs of illness.
The Centers for Disease Control and Prevention (CDC) has identified 61 children from 19 states who have become ill. Six children were hospitalized. There are no reported deaths. States reporting illnesses include: California (seven cases), Colorado (five), Connecticut (two), Georgia (one), Illinois (two), Indiana (one), Massachusetts (four), Minnesota (two), New Hampshire (two), New Jersey (two), New York (15), Oregon (one), Pennsylvania (four), Tennessee (one), Texas (two), Virginia (one), Vermont (three), Washington (four), and Wisconsin (two).
FDA, the States, and CDC are continuing the investigation. Preliminary testing suggests that the seasoning mix used in Veggie Booty may be the source of the contamination. FDA will continue to trace back the ingredients and processing methods used for the seasoning mix, seeing to determine whether the seasoning actually is the source of the problem.
Veggie Booty is sold in a flexible plastic foil bag in four ounce, one ounce and one-half ounce packages. Some gift baskets available for purchase on the internet include Veggie Booty or Super Veggie Tings Crunchy Corn Sticks.
Robert’s American Gourmet ceased distributing Veggie Booty and began recalling the proct on June 28. The company has also voluntarily recalled all lots and sizes of Super Veggie Tings Crunchy Corn Sticks snack food because the same potentially contaminated seasoning may have been used in making that proct, too. In addition, the manufacturer of Veggie Booty and other procts for Robert’s has ceased proction until this investigation is complete. Robert's American Gourmet and its contract manufacturer are fully cooperating with FDA's investigation into the cause of the contamination.
FDA will provide additional updates as the investigation progresses and more information becomes available.
FDA News
FOR IMMEDIATE RELEASE
July 12, 2007
Media Inquiries:
Kris Mejia, 301-827-6242
Consumer Inquiries:
888-INFO-FDA
FDA Approves CustomVue Monovision LASIK
The U.S. Food and Drug Administration approved for marketing the first LASIK device designed for treating one eye to see far away objects and the other eye for close-up vision.
“The approval of the CustomVue Monovision LASIK expands permanent vision correction options for nearsighted alts who also have trouble focusing on objects close-up,” said Daniel Schultz, M.D., director of FDA’s Center for Devices and Radiological Health. “Unlike traditional LASIK, Monovision LASIK may rece the need for reading glasses in some people over 40.”
LASIK, or laser in-situ keratomileusis, is a procere in which the surgeon cuts a flap in the outer layers of the cornea, removes a small amount of the tissue beneath it with the laser, and then replaces the flap. CustomVue Monovision LASIK proces monovision correction in nearsighted (myopic) alts, with or without astigmatism, ages 40 years or older with normal age-related loss of ability to focus on near objects (presbyopia).
The CustomVue device is designed to correct all nearsightedness in the patient’s dominant eye and only part of the nearsightedness in the non-dominant eye. This allows the patient to use the fully corrected eye for distance vision and the under-corrected eye for seeing close up. After a period of time, the brain adjusts to the difference in perception between the two eyes.
People considering CustomVue monovision LASIK should first wear monovision contact lenses for at least a week to determine if they can tolerate having one eye under-corrected. Following monovision surgery, the two eyes may not work together as well as they did before in some patients, especially in dim light or when performing tasks requiring very sharp vision or fine depth perception. Patients may need to wear glasses or contact lenses for some activities such as night driving or reading small type.
CustomVue Monovision LASIK is a permanent operation to the cornea. Side effects may include glare from bright lights, rings around lights (halos), light sensitivity, night driving glare, ghost images, double vision and visual fluctuation.
CustomVue Monovision LASIK is manufactured by AMO/VISX Inc., based in Santa Clara, Calif. The new approval is for the monovision correction, which uses the previously approved wavefront-guided treatments—an eye-mapping system that guides the laser—for myopia and astigmatism. FDA based its approval on the review of a clinical study of safety and effectiveness outcomes submitted by the company.
At FDA’s request, AMO/VISX will conct a post-approval study following 500 patients for six months after surgery to characterize quality of vision and quality of life issues associated with permanent LASIK monovision correction. The objective of the study is to estimate the proportion of monovision LASIK patients who experience visual disturbances that are severe enough to limit activities or adversely affect a patient’s quality of life.
热心网友
时间:2022-06-26 20:46
和我一样,脚掌骨折了,,拖越久越不好治,赶紧拍x光片看看.